Article ID Journal Published Year Pages File Type
8962205 Radiotherapy and Oncology 2018 5 Pages PDF
Abstract
Twice daily schedule of re-irradiation of 60 Gy/5 weeks with cetuximab was tolerable and no significant difference in treatment delays occurred between two arms.
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Cancer Research
Authors
, , , , , , , , , , , ,